Sunday, November 9, 2025
HomeTagsHealthcare

Healthcare

Ascletis Announces U.S. IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors

Ascletis Pharma Inc.  announces the approval of the Investigational New Drug (IND) application by U.S. Food and Drug Administration (FDA) for in-house developed oral...

Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule CD73 Inhibitor ATG-037

Antengene Corporation Limited, a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, announced...

Everest Medicines Announces First Drug Approval of Trodelvy in Singapore

Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced...

InBody Releases New BP 170 Consumer Blood Pressure Device

Blood pressure can fluctuate on a day-to-day basis. Because of this, it's crucial to regularly stay on the pulse of significant shifts, since considerable...

Sabra and Sienna Senior Living Deepen Relationship with Pending Portfolio Acquisition

Sabra Health Care REIT, Inc. announced that, subject to certain closing conditions, the Company along with Sienna Senior Living have agreed to acquire a...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics